Article info
PDFClinical and epidemiological research
Extended report
Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial
- Correspondence to Dr Andra Balanescu, Department of Internal Medicine and Rheumatology, University of Medicine and Pharmacy Carol Davila, Sf. Maria Hospital Research Center on Rheumatic Diseases, Bucharest 11172, Romania; andrab2004{at}yahoo.com
Citation
Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial
Publication history
- Received December 21, 2012
- Revised June 10, 2013
- Accepted June 26, 2013
- First published July 12, 2013.
Online issue publication
June 09, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions